Docoh
Loading...

SYN Synthetic Biologics

Employees

Data from SEC filings
Employee count
CEO pay ratio
CEO Salary
Median Employee Salary

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM


On October 14, 2021, Synthetic Biologics, Inc. (the “Company”) held its 2021 Annual Meeting of Stockholders (the “Annual Meeting”), which had been adjourned twice. At the Annual Meeting, the Company’s stockholders voted on the following four (4) proposals and cast their votes as described below. These matters are described in detail in the Company’s definitive proxy statement on Schedule 14A for the Annual Meeting, which was filed on August 16, 2021 with the Securities and Exchange Commission (the “Definitive Proxy Statement”).

The final results for Proposals 1, 2, 3 and 4 as set forth in the Definitive Proxy Statement are as follows:

Proposal 1 — Election of Directors

The following four (4) individuals were elected as directors, to serve until the Company’s next annual meeting of stockholders and until their respective successors have been duly elected and qualified with the following votes:

Name of DirectorVotes ForWithheldBroker Non-Votes
Jeffrey J. Kraws20,918,85514,514,75731,927,781
Steven A. Shallcross23,667,94111,765,67131,927,781
John Monahan23,662,49611,771,11631,927,781
Jeffrey Wolf21,810,40113,623,21131,927,781


Proposal 2 — Ratification of the appointment of BDO USA, LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2021

The stockholders ratified and approved the appointment of BDO USA, LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2021 based on the votes listed below:

Votes ForVotes AgainstAbstentionsBroker Non-Votes
59,388,7915,632,6242,339,9780


Proposal 3 — Approval of an amendment to the Articles of Incorporation to increase the number of authorized shares of common stock from 200,000,000 to 350,000,000

The stockholders did not approve this proposal to amend the Articles of Incorporation to increase the number of authorized shares of common stock from 200,000,000 to 350,000,000 based on the votes listed below:

Votes ForVotes AgainstAbstentionsBroker Non-Votes
41,677,67624,148,8411,534,8760


Proposal 4 — Authorization of an adjournment of the 2021 Annual Meeting of Stockholders, if necessary, if a quorum is present, to solicit additional proxies if there are not sufficient votes in favor of Proposal 3.

The stockholders approved the authorization of an adjournment of the 2021 Annual Meeting based on the votes listed below; however, the Board of Directors determined not to adjourn the 2021 Annual Meeting of Stockholders to solicit additional proxies in favor of Proposal 3:

Votes ForVotes AgainstAbstentionsBroker Non-Votes
47,294,29417,302,0322,765,0670


Item 9.01.Financial Statements and Exhibits.


(d) Exhibits.


Exhibit
Number
Description
104Cover Page Interactive Data File (embedded within the XBRL document)